The baseline Hb levels in the current study were 11.81 ± 0.71 in the IVIS group and 11.74 ± 0.86 in the OI group, which are similar to baseline levels reported by Rudra et al. and Sudakshina et al [10,11]. The gene discussed is GSTM1; the disease is osteogenesis imperfecta.